Publication | Open Access
Updated Safety and Efficacy from a Phase I Study of Azd9291 in Patients (Pts) with Egfr-Tki-Resistant Non-Small Cell Lung Cancer (Nsclc)
20
Citations
0
References
2014
Year
OncologyPathologyBronchial NeoplasmCancer TreatmentMedicineRadiation OncologyLung CancerCancer Growth
No additional data available for this publication yet. Check back later!